Medivation, Inc. (NASDAQ:MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Recs

0
Player Avatar Biotech2010 (87.49) Submitted: 1/26/2010 8:52:06 PM : Underperform Start Price: $33.60 MDVN Score: -139.06

38.12

Report this Post Reply

Featured Broker Partners


Advertisement